Cannabis Bioscience International Holdings Inc. (CBIH) has announced the addition of a patent-pending nanoemulsion formulation aimed at supporting female fertility and reproductive function in women aged 35 and older. This innovation, which centers cannabinoids combined with antioxidants, polyphenols, fatty acids, and other bioactives, is designed to address age-related reproductive decline by targeting mitochondrial function, redox balance, and cytokine signaling in ovarian and endometrial tissues. The nanoemulsion delivery system improves the solubility and bioavailability of cannabinoids, potentially enhancing tissue exposure at reproductive sites. According to CBIH, the formulation is intended to optimize the follicular microenvironment and support implantation, serving as an adjunct to existing assisted reproductive technologies. The announcement did not specify if or when the research results have been or will be presented publicly.